N 6 ‐ Methyladenosine defines a new checkpoint in γδ T cell development
BioEssays · 2023
DOI: 10.1002/bies.202300002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioEssays, 2023. Verfasst von Jiachen Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, Ch…. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, gamma-delta, Receptors, Antigen, T-Cell, alpha-beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 136 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
T cells, which are derived from hematopoietic stem cells (HSCs), are the most important components of adaptive immune system. Based on the expression of αβ and γδ receptors, T cells are mainly divided into αβ and γδ T cells. In the thymus, they share common progenitor cells, while undergoing a series of well‐characterized and different developmental processes. N 6 ‐Methyladenosine (m 6 A), one of the most abundant modifications in mRNAs, plays critical roles in cell development and maintenance of function. Recently, we have demonstrated that the depletion of m 6 A demethylase ALKBH5 in lymphocytes specifically induces an expansion of γδ T cells through the regulation of Jag1/Notch2 signaling, but not αβ T cells, indicating a checkpoint role of ALKBH5 and m 6 A modification in the early development of γδ T cells. Based on previous studies, many key pathway molecules, which exert dominant roles in γδ T cell fate determination, have been identified as the targets regulated by m 6 A modification. In this review, we mainly summarize the potential regulation between m 6 A modification and these key signaling molecules in the γδ T cell lineage commitment, to provide new perspectives in the checkpoint of γδ T cell development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Institute of Immunology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Hua-Bing Li
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Zhao, J., Ding, C., & Li, H. B. (2023). N 6 ‐ Methyladenosine defines a new checkpoint in γδ T cell development. BioEssays. https://doi.org/10.1002/bies.202300002
Vancouver
Zhao J, Ding C, Li HB. N 6 ‐ Methyladenosine defines a new checkpoint in γδ T cell development. BioEssays. 2023. doi:10.1002/bies.202300002
BibTeX
@article{Zhao2023,
author = {Zhao, Jiachen and Ding, Chenbo and Li, Hua-Bing},
title = {N 6 ‐ Methyladenosine defines a new checkpoint in γδ T cell development},
journal = {BioEssays},
year = {2023},
doi = {10.1002/bies.202300002}
}
EUVIMED